Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4QD6

ITK kinase domain in complex with inhibitor compound

Summary for 4QD6
Entry DOI10.2210/pdb4qd6/pdb
Related4MF0 4MF1
DescriptorTyrosine-protein kinase ITK/TSK, trans-4-({6-[(5-phenyl-1H-pyrazol-3-yl)amino]-4-(phenylsulfonyl)pyridin-2-yl}amino)cyclohexanol (3 entities in total)
Functional Keywordsprotein kinase, phosphotransfer catalyst, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm : Q08881
Total number of polymer chains2
Total formula weight61408.16
Authors
McEwan, P.A.,Barker, J.J.,Eigenbrot, C. (deposition date: 2014-05-13, release date: 2015-01-14, Last modification date: 2024-02-28)
Primary citationTrani, G.,Barker, J.J.,Bromidge, S.M.,Brookfield, F.A.,Burch, J.D.,Chen, Y.,Eigenbrot, C.,Heifetz, A.,Ismaili, M.H.,Johnson, A.,Krulle, T.M.,MacKinnon, C.H.,Maghames, R.,McEwan, P.A.,Montalbetti, C.A.,Ortwine, D.F.,Perez-Fuertes, Y.,Vaidya, D.G.,Wang, X.,Zarrin, A.A.,Pei, Z.
Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK).
Bioorg.Med.Chem.Lett., 24:5818-5823, 2014
Cited by
PubMed: 25455497
DOI: 10.1016/j.bmcl.2014.10.020
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.45 Å)
Structure validation

221051

數據於2024-06-12公開中

PDB statisticsPDBj update infoContact PDBjnumon